Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Enabling Early Detection and Risk Stratification
Arthritis Rheumatol
.
2024 Jul;76(7):999-1001.
doi: 10.1002/art.42827.
Epub 2024 Feb 29.
Authors
Pierre-Antoine Juge
1
2
,
Paul F Dellaripa
2
,
Jeffrey A Sparks
2
Affiliations
1
Hôpital Bichat-Claude Bernard, APHP and Université de Paris, Paris, France.
2
Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
PMID:
38360061
DOI:
10.1002/art.42827
No abstract available
Publication types
Editorial
MeSH terms
Arthritis, Rheumatoid* / complications
Biomarkers*
Early Diagnosis*
Humans
Lung / diagnostic imaging
Lung Diseases, Interstitial* / diagnostic imaging
Lung Diseases, Interstitial* / etiology
Risk Assessment
Substances
Biomarkers
Grants and funding
R01-AR-080659/National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
R01-AR-077607/National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
P30-AR-070253/National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
P30-AR-072577/National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
R. Bruce and Joan M. Mickey Research Scholar Fund
Gordon and Llura Gund Foundation